PyInvesting

Market research

600436.SHG Zhangzhou Pientzehuang Pharmaceutical., Ltd

SHG CNY Healthcare

Latest close

128.58 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
82B
P/E ratio
62.39
Analyst target
155.26
Dividend yield
3.0%
Beta
0.22

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Zhangzhou Pientzehuang Pharmaceutical., Ltd is currently in a long term uptrend where the price is trading 45.9% above its 200 day moving average.

From a valuation standpoint, the stock is 200.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 28.9.

Zhangzhou Pientzehuang Pharmaceutical., Ltd's total revenue rose by 32.1% to $2B since the same quarter in the previous year.

Its net income has increased by 74.9% to $464M since the same quarter in the previous year.

Finally, its free cash flow grew by 146.0% to $937M since the same quarter in the previous year.

Based on the above factors, Zhangzhou Pientzehuang Pharmaceutical., Ltd gets an overall score of 4/5.